Skip to main content

Mimedx Group, Inc.

MDXG
Exchange
Nasdaq
Industry
Surgical & Medical Instruments & Apparatus
SEC CIK
0001376339

No open-market purchases or sales by Mimedx Group, Inc. insiders were filed in the last 90 days; 227 institutions reported holding it in 13F filings for Q2 2026, worth $430.8M in total; no superinvestor holds it.

Open-market trades, last 90 days

Open-market purchases (P) and sales (S) by Mimedx Group, Inc. insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.

Open-market buys
0 filings
Open-market sells
0 filings
Insiders trading
0
Net value
$0
Purchases minus sales

Insider roster

Directors, officers and 10% owners who have filed a Form 4 for Mimedx Group, Inc., current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.

Insider roster for Mimedx Group, Inc.
NameTitleLast reported holdingLast filingFilings, past year
Doug RiceChief Financial Officer399,566Jul 7, 20263
Maersk-Moller KimberlyChief Commercial Officer309,630Jun 25, 20265
Hawkins William ADirector254,931Jun 12, 20261
Bierman James LDirector263,684Jun 12, 20261
Puhy Dorothy EDirector108,510Jun 12, 20261
Olson TiffanyDirector108,510Jun 12, 20261
Newton ToddDirector463,684Jun 12, 20261
Hulse William Frank IVGeneral Counsel and CAO543,195Mar 17, 20263
Capper Joseph HChief Executive Officer904,656Mar 6, 20261
Whitlow Ricci SChief Operating Officer462,825Mar 6, 20262
Behrens M KathleenDirector212,771Jun 23, 20250
Laurencin Cato TDirector181,923Jun 23, 20250
Falcon Fund 2 Holding Company, L.P.10% Owner28,195,249Dec 27, 20230
Gardner PhyllisDirector117,024Jun 15, 20230
Giuliani Michael JDirector130,124Jun 15, 20230
Stein Robert BenjaminPresident, Regenerative Med.317,803May 17, 20230
Carlson Peter MChief Financial Officer656,435May 12, 20230
Phelan William LawrenceChief Accounting Officer184,219May 12, 20230
Kashyap RohitPresident, WC & Surgical430,072Aug 11, 20220
Wright Timothy RChief Executive Officer1,711,324Jun 13, 20220
Graves MarkSVP & Chief Compliance Officer133,608May 10, 20220
Turner Scott MSVP, Operations & Procurement226,643May 4, 20220

Insider trades

Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Feb 18, 2025 (view filing)Feb 135 daysWhitlow Ricci SChief Operating OfficerSSale−61.4K$8.28−$508.6K−13.2%403.0K after
Mar 5, 2025 (view filing)Feb 285 daysLateMaersk-Moller KimberlyChief Commercial OfficerSSale−2.11K$8.41−$17.8K−0.8%265.3K after
Mar 12, 2025 (view filing)Mar 102 daysHulse William Frank IVGeneral Counsel and CAOSSale−81.4K$7.80−$635.3K−14.1%494.8K after
Mar 14, 2025 (view filing)Mar 131 dayMaersk-Moller KimberlyChief Commercial OfficerSSale−4.11K$7.89−$32.4K−1.3%310.8K after
Mar 14, 2025 (view filing)Mar 131 dayHulse William Frank IVGeneral Counsel and CAOSSale−54.6K$7.89−$430.8K−11.0%440.2K after2 lots
Mar 20, 2025 (view filing)Mar 173 daysLateMaersk-Moller KimberlyChief Commercial OfficerSSale−1.76K$8.04−$14.1K−0.6%309.1K after
May 5, 2025 (view filing)May 23 daysCapper Joseph HChief Executive OfficerPPurchase+200.0K$6.34+$1.27M+60.7%529.5K after
Nov 10, 2025 (view filing)Nov 64 daysMaersk-Moller KimberlyChief Commercial OfficerSSale−58.3K$7.42−$432.6K−19.7%237.0K after